Should we stop taking thiazides to prevent kidney stones?

Published Date: 08 Mar 2023

"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.

Read Full News

Latest News

Levothyroxine Discontinuation Safe for Many Older Adults

About 1 in 4 overall and two thirds of those taking doses of 50 µg/d or lower were able to come off the treatment while maintaining adequate thyroid function for 1 year.

Nuanced Sexual and Pelvic Floor Effects of GLP-1s on Women

Emerging research and anecdotal reports suggest that the weight-loss drugs may cause vulvar and urogenital changes.

Patients With Acromegaly Have Higher Risk for Cancer

Patients with acromegaly show a significantly higher risk for cancer than matched control individuals from the general population, with the risk being evident even 5 years before diagnosis.

APHRODITE Model May Improve Care in Male Infertility

A new classification framework introduces structured phenotyping to guide hormonal therapy in male infertility, addressing long-standing reliance on empirical treatment approaches.

Novo Nordisk Launches Higher-dose Wegovy in the United States

Novo Nordisk said on Tuesday that it has made ⁠a higher-dose version of its blockbuster weight-loss drug Wegovy ⁠available across the United States.

Weight Loss After Tirzepatide Varies by Prior Weight Change

Tirzepatide produced notable weight loss in real-world settings, but patients with prior weight loss experienced smaller additional reductions than those without.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Latest News

About 1 in 4 overall and two thirds of those taking doses of 50 µg/d or lower were able to come off the treatment while maintaining adequate thyroid function for 1 year.

Emerging research and anecdotal reports suggest that the weight-loss drugs may cause vulvar and urogenital changes.

Patients with acromegaly show a significantly higher risk for cancer than matched control individuals from the general population, with the risk being evident even 5 years before diagnosis.

A new classification framework introduces structured phenotyping to guide hormonal therapy in male infertility, addressing long-standing reliance on empirical treatment approaches.

Novo Nordisk said on Tuesday that it has made ⁠a higher-dose version of its blockbuster weight-loss drug Wegovy ⁠available across the United States.

Tirzepatide produced notable weight loss in real-world settings, but patients with prior weight loss experienced smaller additional reductions than those without.

News All Time

Sugar Tax Debate Intensifies as Health Evidence Builds

Evidence suggests that sugar taxes may influence obesity patterns among younger populations.

Airline Websites Vary on Info for Passengers With Obesity

Across 50 leading airlines globally, all offer some content for passengers with obesity, but the specifics vary widely.

Gene Therapy to Be Studied for Treating Type 1 Diabetes

A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

Viridian Eye Disease Drug Disappoints on Efficacy Despite Trial Success

Viridian Therapeutics' experimental treatment for thyroid eye ⁠disease lagged rivals in efficacy in a late-stage...

Beyond Diabetes Control: Tirzepatide Boosts Quality of Life

Switching to tirzepatide yields greater quality-of-life benefits than increasing the dulaglutide dose in patients with type 2 diabetes.

BMI Misclassifies Many Adults With Obesity

Researchers using the gold-standard DEXA to measure body fat percentage showed that BMI misclassified a notable proportion of adults, placing many in incorrect weight categories.

Novo Nordisk Cuts Ozempic, Wegovy Prices in India Again to Fight Cheaper Generics

Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and ⁠48% in India, to fend off competition from...

Tirzepatide Boosts Metabolic Health in Partial Lipodystrophy

Tirzepatide significantly improves metabolic health and reduces insulin dependence in patients with partial lipodystrophy.

EMA Clears New First-Line Options for Advanced Cancers

European regulators have backed RET inhibitor and PD-1 regimens, expanding first line options in advanced lung, thyroid, and esophageal cancers.

NICE Introduces Endometriosis Fertility Pathway

An updated NICE guideline sets out a dedicated pathway for endometriosis within wider fertility guidance.

Weight Loss May Cut Cancer Risk in Adults With Obesity

Nonsurgical weight loss is associated with reduced incident risks for both obesity-related and other cancers in adults with obesity.

Medtronic Gets US FDA Nod to Use Surgical System in Cranial, ENT Surgeries

Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system ⁠for cranial and ear, nose and throat procedures, expanding the platform...

EU Reaffirms Rejection of Rare Sleep Disorder Drug

The sleep drug failed to gain approval for nighttime disruptions in children with a rare genetic disorder affecting circadian rhythm patterns.

Experts Question Evidence for New Testosterone Advice

New federal dietary guidance includes advice on boosting testosterone levels, which clinicians say is only partially rooted in evidence.

Once- or Twice-Yearly Injection for Weight Loss?

Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.

Do ESAs for Anemia Raise Cancer Risk in Dialysis Patients?

High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

Recommended News For You

The use of biomarkers in the treatment of breast lumps is at a crossroads.

After cancer: Study explores caring-healing modalities for survivors

Safe and acceptable telehealth suicide prevention program.

Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis

Slowdown in progress found with cancer survival in England and Wales

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

Advancing Health in Africa

Recommended Articles For You

Synovial Sarcoma of Female Urethra: Case Report and Literature Review 

Understanding SVR Normal Range: A Guide to Achieving Optimal Health 

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients 

Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

As pesticides and wildfires rise, kids with cancer need resources

2.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

3.

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

4.

Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients

5.

A paper strip test might enable the early detection of cancer.

1.

The Mystery of Carotid Body Tumors: The Facts You Need to Know

2.

Emicizumab in Infants with Severe Hemophilia A: HAVEN 7 Phase 3b Trial Insights

3.

Targeting Oncology: Expanding Combinatorial Strategies by 2025

4.

The benefits of using magnesium sulfate during pregnancy 

5.

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

3.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

4.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

5.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot